Company Description
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.
It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions.
In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.
The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
| Country | United States |
| Founded | 2008 |
| IPO Date | Oct 25, 2019 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 856 |
| CEO | Peter Anevski |
Contact Details
Address: 1359 Broadway New York, New York 10018 United States | |
| Phone | 212 888 3124 |
| Website | progyny.com |
Stock Details
| Ticker Symbol | PGNY |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $13.00 |
| CIK Code | 1551306 |
| CUSIP Number | 74340E103 |
| ISIN Number | US74340E1038 |
| Employer ID | 27-2220139 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| David J. Schlanger J.D. | Executive Chairman |
| Melissa B. Cummings | Chief Operating Officer |
| Allison Swartz | Executive Vice President, General Counsel and Secretary |
| Geoffrey Clapp | Chief Product Officer |
| Steven Leist | Chief Technology Officer |
| James Hart | Vice President of Investor Relations |
| Risa Fisher | Chief Marketing Officer |
| Cassandra Pratt | Chief Human Resources Officer |
| Julie Stadlbauer | Chief Business Development Officer |
| Janet Choi M.D. | Member of the Medical Advisory Board and Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2026 | ARS | Filing |
| Apr 10, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 10, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 31, 2026 | PRE 14A | Other preliminary proxy statements |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Mar 13, 2026 | 8-K | Current Report |
| Mar 4, 2026 | 144 | Filing |
| Mar 3, 2026 | 144 | Filing |
| Mar 2, 2026 | 144 | Filing |
| Feb 27, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |